Skip to main content

Avricore Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (AVCR)

AI-generated - The Globe and Mail - Tue May 13, 2025

Avricore Health is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ADKDiagnos--- (0.0%)0.00.00.0
AJAAJA Health and Wellness--- (0.0%)0.00.00.0
AQSAequus Pharmaceuticals--- (0.0%)0.00.00.0
ARCARCpoint--- (0.0%)0.00.03.6
ARCHArch Biopartners--- (0.0%)0.00.00.0
ASGAurora Spine--- (0.0%)0.00.00.0
AVCRAvricore Health--- (0.0%)0.00.00.0
CANBCanadaBis Cap--- (0.0%)0.00.00.0
CHSComprehensive Healthcare--- (0.0%)0.00.00.0
CNVIConavi Medical--- (0.0%)0.00.00.0

All data provided as of May 13, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Avricore Health

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

Avricore Health is listed under AVCR on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.